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Objective: To investigate whether an exercise program, initially focusing on knee stabilization and sub-
sequently on muscle strength and performance of daily activities is more effective than an exercise
program focusing on muscle strength and performance of daily activities only, in reducing activity
limitations in patients with knee osteoarthritis (OA) and instability of the knee joint.
Design: A single-blind, randomized, controlled trial involving 159 knee OA patients with self-reported
and/or biomechanically assessed knee instability, randomly assigned to two treatment groups. Both
groups received a supervised exercise program for 12 weeks, consisting of muscle strengthening exer-
cises and training of daily activities, but only in the experimental group speciﬁc knee joint stabilization
training was provided. Outcome measures included activity limitations (Western Ontario and McMaster
Universities Osteoarthritis Index eWOMAC physical function, primary outcome), pain, global perceived
effect and knee stability.
Results: Both treatment groups demonstrated large (w20e40%) and clinically relevant reductions in
activity limitations, pain and knee instability, which were sustained 6 months post-treatment. No dif-
ferences in effectiveness between experimental and control treatment were found on WOMAC physical
function (B (95% conﬁdence interval e CI) ¼ 0.01 (2.58 to 2.57)) or secondary outcome measures,
except for a higher global perceived effect in the experimental group (P ¼ 0.04).
Conclusions: Both exercise programs were highly effective in reducing activity limitations and pain and
restoring knee stability in knee OA patients with instability of the knee. In knee OA patients suffering
from knee instability, speciﬁc knee joint stabilization training, in addition to muscle strengthening and
functional exercises, does not seem to have any additional value.
Dutch Trial Register (NTR) registration number: NTR1475.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.: J. Knoop, Reade, Centre for
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s Research Society International. POsteoarthritis (OA) of the knee leads to more chronic activity
limitations among the elderly than any other disease1. However, no
curative treatment is currently available2. Exercise therapy, which
mainly concerns strength training, is considered an essential
treatment in knee OA and is recommended in international
guidelines2e4. Systematic reviews5e7 clearly report the beneﬁcial
effects of exercise therapy in knee OA. However, these effects are
moderate at best, with mean effect sizes of 0.40 and 0.37 reported
for pain and activity limitations, respectively, compared to no ex-
ercise5. By improving the content of exercise programs, as well asublished by Elsevier Ltd. All rights reserved.
J. Knoop et al. / Osteoarthritis and Cartilage 21 (2013) 1025e10341026the selection of patients, effects of exercise therapy might be
improved.
Knee instability, which can be deﬁned as the inability to main-
tain a position or control movements of the knee joint under
differing external loads8, has recently become a focus of research in
knee OA. Patient-reported knee instability, described as ‘a feeling of
giving way, shifting or buckling of the knee during daily activities’,
was found to be prevalent in a majority (>60%) of knee OA pa-
tients9e11 and independently associated with activity limitations
(even after adjusting for pain, muscle weakness and radiographic
severity)9,10,12. Dynamic neuromuscular control, which is provided
by the interaction of proprioceptive stimuli (i.e., perception of po-
sition and movement of an extremity or a joint in space13) and
muscle actions, and the passive restraint system (i.e., ligaments and
capsule) are thought to be responsible for knee stabilization8.
Muscle weakness in the upper leg is an established risk factor
for activity limitations in knee OA, based on longitudinal data14.
Recent cross-sectional studies from our group15e18 suggested that
the relationship between muscle weakness and activity limita-
tions is affected by biomechanical factors involved in the knee
joint stabilization process, namely proprioceptive accuracy of the
knee, varusevalgus laxity of the knee (i.e., passive restraint sys-
tem), and varusevalgus knee motion during walking. In these
studies, muscle weakness was found to be more strongly related
to activity limitations in those patients with impaired proprio-
ceptive accuracy15,16, high laxity17, or high knee motion during
walking18 than in patients with adequate proprioceptive accuracy,
low laxity, or low kneemotion during walking. These ﬁndings may
suggest that when upper leg muscles are weak and other
biomechanical factors involved in the knee joint stabilization
process are impaired as well, the knee joint becomes unstable, and
more severe activity limitations may ensue (according to Neuro-
muscular model, see Fig. 1).
More importantly, these ﬁndings could imply that knee OA pa-
tients with knee instability may not beneﬁt optimally from standard
exercises targeting muscle strength. An exercise program that addi-
tionally targetsotherbiomechanical factors involved in theknee joint
stabilization process could be more beneﬁcial for this subgroup.
Moreover, knee joint stabilization trainingmayneed tobespeciﬁcally
provided in the ﬁrst, low-intense phase of the intervention, prior to
higher-intensity strength training, as patients suffering from knee
instabilitymay not be able to perform strengthening exercises safely
(i.e., without risking joint-speciﬁc adverse events)19, Currently, such
an intervention has not been evaluated.
This study aims to investigate whether an exercise program,
initially focusing on knee stabilization and subsequently on muscle
strength and performance of daily activities is more effective than
an exercise program focusing on muscle strength and performanceFig. 1. Neuromuscular model.of daily activities only, in reducing activity limitations in patients
with knee OA and instability of the knee joint.
Methods
Trial design
This study isa single-blind, randomized, controlled trial, conducted
in an outpatient rehabilitation center (Reade, centre for rehabilitation
and rheumatology, Amsterdam, the Netherlands), approved by the
Medical Ethical Review Board (Reade/Slotervaart Hospital) and in
compliance with the Helsinki declaration. The assessor (SR) who
performed measurements was blinded for group allocation.
Participants
Participants were recruited from February 2009 to March 2011
through advertisements in local and regional newspapers and from
regular referral from rheumatologists or rehabilitation physicians
from our rehabilitation center. Participants’ eligibility was ﬁrst
assessed by screening questionnaire and telephone screening by
the researcher, and subsequently by physical examination by a
rheumatologist, rehabilitation physician and assessor. All partici-
pants provided written informed consent.
Inclusion criteria were (1) diagnosis of knee OA according to clin-
ical American College of Rheumatology (ACR) criteria20, (2) age be-
tween 40 and 75 years, and (3) presence of self-reported and/or
biomechanically assessed knee instability. Self-reported knee insta-
bilitywasdeﬁned as at least one episodeof buckling, shiftingor giving
way of the knee in the past 3 months, reported by the patient21.
Biomechanicallyassessedknee instabilitywasdeﬁnedas thepresence
of muscle weakness (i.e., bodyweight-adjusted isokinetic hamstrings
strength 0.80 Nm/kg for men or 0.55 Nm/kg for women) in com-
bination with presence of (1) impaired proprioceptive accuracy (i.e.,
score 4.3) and/or (2) high passive varusevalgus laxity (i.e., score
4.6 formen or7.7 forwomen).Mean scores from both legs were
used; cut-off points were based on previous data15,17.
Exclusion criteria were (1) other forms of arthritis than OA (e.g.,
crystal arthropathy, septic arthritis, spondyloarthropathy) identi-
ﬁed by radiography and/or blood- and urine samples, (2) presence
of comorbidity resulting in severe activity limitations, (3) total knee
arthroplasty (TKA) or TKA in near future, (4) severe knee pain (i.e.,
numeric rating scale (NRS) >8), (5) insufﬁcient comprehension of
Dutch language, (6) inability to be scheduled for therapy, and (7)
unwillingness to give informed consent.
Randomization
A computer generated random sequence for group allocation
was made prior to the study, using a permutated block randomi-
zation procedure comprising four participants per block. This
randomization technique was chosen to ensure equal sample sizes
between the two treatment groups. Group allocationwas concealed
by opaque, sealed, consecutively numbered envelopes. Every 12
weeks, around 16 eligible patients were randomly allocated (allo-
cation ratio 1:1) over two parallel treatment groups (experimental
and control group). In total, the study consisted of 11 consecutive
pairs of parallel treatment groups.
Interventions
Experimental intervention
The experimental intervention comprised an exercise program
of twelve weeks, with two sessions of 60 min weekly, and a home
exercise program for 5 days weekly (non-treatment days only),
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difﬁculty during the program. The exercise program consisted of
three phases: ﬁrst phase (week 1e4) targeting knee joint stabili-
zation, second phase (week 5e8) targeting muscle strength (i.e.,
muscle endurance) in addition to knee joint stabilization, and third
phase (week 9e12) targeting performance of daily activities in
addition to knee joint stabilization and muscle strength (i.e.,
maximal muscle power). In the ﬁrst week only, sessions were
located in a swimming pool to minimize knee loading, while from
the second week, land-based therapy was provided.
In the ﬁrst phase (week 1e4), speciﬁc knee joint stabilization
training was provided. This training speciﬁcally focused on
perception of knee position and motion to improve proprioceptive
accuracy, and on maintenance of static or dynamic control of the
knee (i.e., neuromuscular control22) to limit consequences of high
laxity and to minimize high knee motion. Exercises in this phase
were of relatively low intensity, to enable the patients to optimally
focus on knee stabilization, and were performed with minimal
knee load, to avoid joint-speciﬁc adverse events (e.g., pain ﬂares,
giving way of the knee). Exercises consisted of three sets of 15
repetitions. In addition, three educational sessions (i.e., information
concerning OA disease, risk factors for functional decline and advice
on self-management) were provided.
In the second phase (week 5e8), muscle strengthening exercises
were added to the program, targeting muscle endurance. Training
intensity and knee load gradually increased each week, but
remained sub-maximal. Moreover, knee stabilization training
increased in difﬁculty. Exercises consisted of three sets of 15 rep-
etitions (in week 5 and 6) or 20 repetitions (in week 7 and 8).
In the third phase (week 9e12), functional, patient-tailored
exercises, targeting speciﬁc daily activities which were indicated
to be relevant and problematic by the patients themselves, and
aerobic training (e.g., cross-trainer, treadmill) were added to the
program. Training intensity and knee load further gradually
increased each week to maximum level as possible, targeting
maximal muscle power. In addition, knee stabilization training
further increased in difﬁculty. Exercises consisted of three sets of 10
repetitions. Finally, participants were encouraged to remain phys-
ically active after completion of the exercise program. See
supplementary ﬁle for more detailed information.
Control intervention
Patients in the control group received exercise therapy sessions
of 60 min twice weekly for 12 weeks (hydrotherapy in ﬁrst week,
land-based therapy from week 2), including home exercises for
5 days a week, similar to the experimental group. The control
intervention consisted of only two phases: ﬁrst phase (week 1e8)
targeting muscle strength (i.e., muscle endurance), and second
phase (week 9e12) targeting performance of daily activities in
addition to muscle strength (i.e., maximal muscle power).
In the ﬁrst 4 weeks, exercises of low intensity and minimal knee
load were provided, in addition to education on knee OA. From
week 5, training intensity and knee load gradually increased, with
muscle strengthening exercises targeting muscle endurance in
week 5e8 and maximal muscle power in week 9e12, and with
addition of functional and aerobic exercises fromweek 9, similar to
the experimental intervention.
Contrast between interventions
The experimental intervention differed from the control inter-
vention in the presence of speciﬁc knee joint stabilization training,
consisting of (1) instructions and feedback on knee position and
motion; and (2) speciﬁc exercises.
During the entire program, but explicitly in the ﬁrst 4 weeks,
patients in the experimental group were extensively instructed tofocus on their knee position and to control this position (e.g.,
maintaining neutral knee alignment, avoiding sudden movements
of the knee (e.g., giving way)). For this purpose, while exercising,
patients received verbal and tactile feedback from physical thera-
pists and visual feedback from mirrors on knee position. Although
training intensity, knee load and difﬁculty of exercises increased
during the program, patients were instructed to keep performing
exercises in a controlled manner. Physical therapists from the
control group were not allowed to provide instructions and feed-
back on knee position, meaning that patients from this group could
perform exercises in any way they saw ﬁt.
Additionally, only the experimental group received speciﬁc ex-
ercises, in which patients were challenged to maintain adequate
knee position (see Fig. 2 for an example). Patients from the control
group did not receive these speciﬁc exercises.
Training intensity and amount of attention from the physical
therapists were intended to be similar in both groups.
Physical therapists
Each group, consisting of approximately eight patients, was
supervised by two physical therapists, speciﬁcally trained to pro-
vide the particular treatment. Every 12 weeks, booster training
sessions for participating physical therapists were provided, for
experimental and control treatment separately. Physical therapists
(n ¼ 17) were assigned to only one treatment arm.
Outcomes
Primary outcome measure
Self-reported activity limitations was assessed by the Dutch
translation of the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC), subscale physical function23,24.
Secondary outcome measures
Knee pain severity during the last week was scored on an
NRS ranging from0 to10 (0¼nopain; 10¼worst pain imaginable)25.
Global perceived effect (GPE) was assessed on a 7-point scale
(ranging from 1 ¼ symptoms have never been worse, to
7¼ symptoms are completely gone) anddichotomized as ‘improved’
(score 5e7) or ‘not improved’1e4. Self-reported knee joint instability
(i.e., episode of buckling, shifting or giving way of the knee in the
past 6 weeks21) andwhether this knee instability resulted in activity
limitations9 were assessed by questionnaire. Isokinetic muscle
strength of the upper leg (quadriceps and hamstrings strength) and
proprioceptive accuracy of the knee (threshold detection of motion)
were assessed as described in previous studies15. The Get Up and Go
(GUG) test26 was used to assess observed activity limitations. Self-
reported performance of three daily activities most relevant to the
patient was determined by the Patient Speciﬁc Functioning List
(PSFL)27. Walking Questionnaire (WQ35)28, Climbing Stairs Ques-
tionnaire (CStQ15)29 and Questionnaire Rising and Sitting down
(QR&S39)30 were used to assess speciﬁc lower-extremity related
limitations in daily activities and have been validated in OA patients.
In addition, baseline demographics were obtained.
For knee-speciﬁc variables we used data from one knee per
person (index knee). Index knees were determined as follows: (1)
knee with clinical diagnosis of knee OA according to ACR-criteria;
(2) in case of clinical diagnosis of knee OA in both knees, knee
that fulﬁlled criteria for biomechanically assessed knee instability
(based on cut-off points for muscle weakness in combination with
impaired proprioceptive accuracy and/or high laxity; see
Participants); (3) in case of biomechanically assessed knee insta-
bility in both knees or none at all, knee that fulﬁlled criteria for self-
reported knee instability; (4) in case of self-reported knee insta-
bility in both knees or none at all, a knee was randomly chosen.
Fig. 2. Example of knee stabilization exercise. Exercise: forward lunge step under sideways knee load by use of dyna band, emphasizing on neutral alignment of the knee: no valgus
position (left photo) or varus position (right photo), but knee position in line with hip and ankle (centered photo).
Table I
Baseline characteristics of experimental and control group
Experimental
group (n ¼ 80)
Control group
(n ¼ 79)
Mean  SD n (%) Mean  SD n (%)
Age (years) 62.1  7.6 61.8  6.6
Gender (female) 53 (66) 44 (56)
Duration of knee symptoms 10.8  9.7 10.7  8.8
BMI (kg/m2) 28.8  4.8 28.3  4.5
Clinical knee OA (according to
ACR-criteria)
Unilateral 21 (26) 19 (24)
Bilateral 59 (74) 60 (76)
Radiographic severity of knee*
K/L grade 0/1 31 (39) 25 (32)
K/L grade 2 23 (29) 21 (27)
K/L grade 3 18 (23) 23 (29)
K/L grade 4 8 (10) 10 (13)
Education level
Primary 1 (1) 2 (3)
Secondary 55 (69) 57 (72)
College/university 24 (30) 20 (25)
Comorbidity score (CIRS, 0e52) 3.7  4.5 3.7  4.7
Use of pain medication (including
NSAIDs)
35 (44) 37 (47)
Use of walking device (like brace,
cane)
16 (20) 10 (13)
Alignment of knee*
Varus malalignment (5 varus) 14 (18) 24 (30)
No varus malalignment 66 (82) 55 (70)
Upper leg muscle strength
(Nm/kg)*
0.83  0.35 0.85  0.43
Proprioceptive accuracy of knee
(degrees)*
2.7  2.2 3.7  2.6
Varusevalgus laxity of knee
(degrees)*
7.0  3.1 7.1  4.5
WOMAC (physical function, 0e68) 25.2  11.8 27.1  12.7
NRS (knee pain severity, 0e10) 4.8  2.2 5.2  2.0
Knee instability, self-reported
One episode in past six weeks,
yes
67 (84) 65 (82)
Resulting in activity limitations,
yes
39 (49) 53 (67)
SD ¼ standard deviation; BMI ¼ body mass index; K/L ¼ Kellgren/Lawrence;
CIRS ¼ cumulative illness rating scale; NSAID ¼ non-steroidal anti-inﬂammatory
drug.
* Data from index knee.
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at baseline and at three follow-up (FU) points: at 6-week FU (mid
treatment), 12-week FU (directly post-treatment) and 38-week FU
(6 months post-treatment). Serious adverse events, deﬁned as falls,
injuries or severe illness during exercising were collected by the
researcher. Therapists assessed patient-perceived training intensity
on a Borg-scale31 after each session, and pain severity (NRS) during
the past week, which could be used for individual adaptations of
the exercise protocol. In addition, at 38-week FU, GPE in compari-
son to directly post-treatment, adherence to the home exercises,
level of physical activity and use of health care during 6-months FU
period were assessed.
Blinding
Randomization, treatment allocation and statistical analyses
were performed blindly. The assessor (SR), who measured all par-
ticipants, was blinded for treatment allocation. Allocation of each
participant was guessed by the assessor at the 12-week FU mea-
surement to check blinding. Due to the nature of the interventions,
neither the patients nor the therapists could be blinded. However,
no informationwas given to the patients on the hypothesized most
beneﬁcial treatment.
Sample size
The a priori power calculation was based on a signiﬁcance level
of a ¼ 0.05, an expected autocorrelation between the repetitions of
0.60, a desired power (1  b) of 0.90 and a cautious estimate of 0.3
as the minimally expected difference in effect size between
experimental and control group at 12-week FU. Given these pa-
rameters, a total sample size of 108 patients was needed. Allowing
for an attrition rate of 10% during the study, we aimed to include at
least 120 patients (i.e., two groups of 60 patients).
Statistical analyses
Data were analyzed using PASW Statistics 18.0 (SPSS Inc, Chi-
cago, IL). Baseline descriptives were compared between groups.
Generalized Estimating Equation (GEE) analysis, a longitudinal
regression analysis technique analyzing all time points (i.e., 6-
week, 12-week and 38-week FU) at once with adjustments for
dependence of repeated measures within individual participants32,
was performed (using exchangeable correlation matrix). Group
differences on average over time and interactions between group
and time were estimated, adjusting for baseline value of outcomemeasure and relevant baseline variables that were different be-
tween groups (i.e., varus knee alignment, proprioceptive accuracy
and self-reported knee instability affecting daily functioning; see
Table I). Prior to analysis, outcome measures were checked for
normality. All outcomes measures were considered normally
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tive accuracy, WQ35 and QR&S, which were therefore transformed
by log10 (for proprioceptive accuracy) or square root (for WQ35
and QR&S).
Primary analyses were based on intention-to-treat (ITT)
approach, in which data of all patients were analyzed according to
group assignment. Standardized mean differences (SMD)33,34 were
calculated for the differences between interventions (between-
group effect size) and for each intervention separately (within-
group effect sizes). Additionally, relative changes (%) and treatment
response, based on minimal clinically important differences
(MCID)26,27,35,36 were calculated. Secondary analyses included
sensitivity analyses with a ‘last observation carried forward’
imputation method for missings and per-protocol analyses,
excluding protocol violators (i.e., patients discontinued treatment,
missing more than eight out of 24 sessions or undergone knee
surgery during study period). P values less than 0.05 were
considered statistically signiﬁcant.
Results
Participant’s ﬂow chart is presented in Fig. 3. From a total of 539
potential candidates, 380 were excluded, mostly because of refusal/Assessed for e
(n=539)
Intention to treat analysis (n=79)
Per-protocol analysis (n=71)
Complete data (n=76)
Allocated to experimental group (n=80)
Received allocated intervention (n=79)
Did not receive allocated intervention (n=1)
- withdrawal before intervention due to 
lack of time (n=1)
Allocati
Analys
Randomized (
Enrollme
6/12-We
follow-u
Follow-up (n=79)
Lost to follow-up (n=0)
Missed 6-week follow-up (n=1)
Protocol violators (n=6)
- discontinued treatment, due to health 
condition (n=2)
- missed ≥ 8 out of 24 sessions (n=4)
38-Wee
follow-u
Follow-up (n=79)
Lost to follow-up (n=0)
Data from questionnaires only (n=2)
Protocol violators (n=2)
- TKA in FU period (n=1)
- knee arthroscopy in FU period (n=1)
Fig. 3. Flowinability to participate (e.g., costs, time restrictions) (n ¼ 197).
Therefore, 159 participants were included, of which 70% fulﬁlled
criteria for self-reported knee instability only, 6% criteria for
biomechanically assessed knee instability only, and 23% both
criteria. Eighty people were allocated to experimental group, 79 to
control group. One person from the experimental group (reason:
lack of time) and four from the control group (reasons: health
problems unrelated to OA (n¼ 3) and lack of time (n¼ 1)) were lost
before the ﬁrst FU measurement, meaning that data from 154
participants were available for the ITT analysis. Thirteen partici-
pants (eight from experimental group; ﬁve from control group)
were considered protocol violators and excluded from per-protocol
analyses.
Baseline characteristics of the experimental and control group
are presented in Table I. Participants attended 21 out of 24 sessions
and performed home exercises during the exercise program for 4
days a week on average, similarly in both groups. In both groups,
perceived training intensity, reported by patient on Borg-scale,
gradually increased during the 12-week program and was on
average similar between groups (11.8  1.0 and 11.7  1.1 for
experimental and control group, respectively; P ¼ 0.33). However,
course of training intensity slightly differed between groups, as
perceived intensity in experimental group was signiﬁcantly higherligibility 
Excluded  (n=380)
Not meeting inclusion criteria (n=167)
- no knee OA diagnosis (n=14)
- age not between 40-75 (n=10)
- comorbidity severely affecting daily
functioning (n=30)
- TKA (in near future) (n=45)
- absence of knee instability (n=65)
- severe knee pain (NRS>8) (n=9)
Refusal/inability to participate (n=197)
Other reasons (n=10)
Allocated to control group (n=79)
Received allocated intervention (n=79)
Did not receive allocated intervention (n=0)
Intention to treat analysis (n=75)
Per-protocol analysis (n=70)
Complete data (n=74)
on
is
n=159)
nt
ek 
p 
Follow-up (n=75)
Lost to follow-up (n=4)
- withdrawal before 6-week FU, due to health 
condition (n=3) or lack of time (n=1)
Protocol violators (n=3)
- missed ≥ 8 out of 24 sessions (n=3)
k 
p 
Follow-up (n=75)
Lost to follow-up (n=0)
Data from questionnaires only (n=1)
Protocol violators (n=2)
- TKA in FU period (n=2)
chart.
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9.8  1.7; P ¼ 0.03), while signiﬁcantly lower in the last 4 weeks
(12.9  1.3 vs 13.5  1.4; P ¼ 0.01) (see Fig. 4). No serious adverse
events had been reported. Group allocation was guessed correctly
by the assessor in 59% of the participants (k ¼ 0.18).
No signiﬁcant group differences on average over time or in-
teractions between group and time were found on primary
outcome WOMAC physical function or on secondary outcomes,
except for a signiﬁcantly higher GPE in the experimental group
directly post-treatment (87% vs 73% in control group; OR (95%
CI) ¼ 2.4 (1.0e5.8)) (see Table II). Per-protocol analyses did not lead
to different study results, although all outcomes slightly changed in
favor of the experimental group.
As shown by Table III, both interventions were found to be
effective on each outcomemeasure. Approximately two third of the
participants demonstrated clinically relevant improvements on
activity limitations and pain, based on MCID, which were sustained
6 months later [see also Fig. 5(a and b)]. Furthermore, a large ma-
jority of the participants (78% and 77% in experimental and control
group, respectively) indicated their symptoms remained stable or
even improved during the 6-month period post-treatment.
No difference in effectiveness between treatments could be
demonstrated, as between-group effect size of 0.06 for WOMAC
physical function and 0.09 for NRS pain severity were found.
Within-group effect size for the experimental treatment were 0.77
(WOMAC physical function) and 0.91 (NRS pain), and for the control
treatment 0.72 and 0.93, respectively.Discussion
In this study, we determined the additional effect of initial knee
joint stabilization training, prior to strength training and training of
daily activities, in persons with knee OA suffering from knee
instability. We could not conﬁrm our hypothesis that speciﬁc knee
joint stabilization training has additional value in this targeted
subgroup of patients, as both treatment groups demonstrated
similarly large and clinically relevant improvements on activity
limitations, pain and knee instability. Only on one secondary
outcome measure (i.e., GPE), we found a signiﬁcant difference, in
favor of the experimental group.
In recent years, two studies37,38 have already been conducted in
knee OA patients to determine the effect of knee stabilization
training in addition to strength training. The ﬁrst was a small non-
randomized study37 in 60 female knee OA patients, demonstrating
signiﬁcant but small effects of ‘kinesthetic (i.e., proprioceptive) and
balance training’ in addition to strengthening exercises, comparedFig. 4. Patient-perceived training intensity (Borg-scale31) for control and experimental
group separately.to strengthening exercises only. However, because of a higher
training intensity of the experimental program39, a high drop-out
rate (32%) and the lack of randomization, evidence for an addi-
tional effect of knee stabilization training was not provided. The
second study was a large randomized controlled trial38 in 183 knee
OA patients, focusing on the additional effect of agility and
perturbation exercises, which exposes patients to challenges in
balance, in addition to strengthening exercises. Again, no additional
effect could be demonstrated. Unlike these two studies, we selected
participants based on the presence of knee instability, as particu-
larly these patients were presumed to beneﬁt from an exercise
program that speciﬁcally targets knee stabilization. Surprisingly,
we were also unable to demonstrate an additional effect of knee
stabilization training.
Our study results, along with the studies from Diracoglu et al.37
and Fitzgerald et al.38, may imply that knee stability can be
improved through strength training, without necessarily adding
speciﬁc knee stabilization training. Multiple studies37,40e42 in knee
OA patients showed that proprioception can be improved through
exercises. We found improvements of w30% in proprioceptive ac-
curacy and reductions ofw30% in self-reported knee instability in
both groups, while Diracoglu et al.37 reported even larger propri-
oceptive improvements in patients receiving strength training with
and without additional proprioceptive training. These effects of
strength training could be attributed to an increase in amount43
and sensitivity13 of muscle spindles, which are considered the
most important sources of proprioceptive stimuli44, and to a
decrease in muscle fatigue45 and level of muscle contraction,
relative to maximum level46, which may all positively inﬂuence
proprioceptive accuracy and knee stability43. In addition, we
demonstrated in a previous study11 that lowmuscle strength of the
upper leg was strongly related to the presence of self-reported knee
instability in a knee OA cohort, while unexpectedly, impaired
proprioceptive accuracy and high laxity were not. These results
consistently indicate that the role of upper leg muscles in knee
stabilization seem to be dominant over other biomechanical factors
involved in the knee joint stabilization process.
We revealed large within-group effect sizes of 0.8 for activity
limitations and 0.9 for pain severity, which are at the higher end of
within-group effects previously reported for exercise programs in
large knee OA studies38,47e50. Moreover, clinically relevant im-
provements were found in two out of every three participants.
These large effects presumably indicate a well-chosen content of
our programs, including strengthening, aerobic and functional ex-
ercises plus education, as well as an adequate gradual increase in
training intensity, all according to recent guidelines2e4. Further-
more, exercises were linked to daily activities like walking, stair-
climbing and rising from a chair into our exercises, which may be
important to reduce activity limitations. Finally, no adverse events
(e.g., pain ﬂares, knee injuries) occurred during the interventions,
which is possibly attributable to the low intensity and minimal
knee loading of exercises in the ﬁrst phase, with gradual increase
during the program, as illustrated in Fig. 4.
In contrast to previous studies5,51, treatment effects in the pre-
sent study hardly changed 6 months after the intervention. Crucial
factors for long-term effects have been found to be adherence to
home exercises and being physically active in daily life51. Our par-
ticipants were highly adherent, both during the exercise program
(i.e., 21 out of 24 treatment sessions were attended on average) and
post-treatment (i.e., 78% of the participants continued performing
home exercises after the intervention), and a majority of the par-
ticipants (53%) increased their physical activity level, compared to
baseline. These results may possibly be ascribed to the feasibility of
the exercises, a strong link between exercises and daily activities
and adequate education, which included self-management advice.
Table II
Outcome measures by group at different time-points (mean  SD unless otherwise stated) and group differences over time (ITT-analysis)
Baseline 6-Wk FU (mid treatment) 12-Wk FU (directly
post-treatment)
38-Wk FU (6 months
post-treatment)
Group differences
over time (6-, 12-
and 38-wk FU)*
Exp. Con. Exp. Con. Exp. Con. Exp. Con. B (95% CI) P
Primary outcome
WOMAC (physical function,
0e68)
25.2  11.8 27.1  12.7 21.5  11.6 21.8  10.4 17.4  11.6 19.3  11.4 18.9  13.3 19.2  13.2 0.01 (2.58 to 2.57) 0.99
Secondary outcomes
NRS (knee pain severity, 0e10) 4.8  2.2 5.2  2.0 3.7  2.1 3.9  1.9 2.8  2.1 3.3  2.1 3.1  2.5 3.7  2.4 0.26 (0.76 to 0.23) 0.30
GPEy, n (%) n/a n/a n/a n/a 69 (87) 55 (73) n/a n/a 2.44 (1.02e5.84)k,{ 0.04
Knee instability, self-reported
One episode in past 6 weeks,
n (%)
67 (84) 65 (84) 53 (68) 54 (72) 41 (52) 41 (55) 41 (51) 30 (40) 1.07 (0.64e1.67)k 0.80
Resulting in activity limitations,
n (%)
39 (49) 53 (67) 27 (35) 27 (36) 18 (23) 24 (32) 22 (28) 29 (39) 0.93 (0.54e1.58)k 0.79
Upper leg muscle strength
(Nm/kg)z
0.83  0.35 0.85  0.43 0.92  0.35 0.94  0.39 0.97  0.32 1.01  0.42 1.00  0.36 1.04  0.40 0.01 (0.06 to 0.05) 0.79
Proprioceptive accuracy
(degrees)z
2.7  2.2 3.7  2.6 2.4  1.9 2.5  1.6 2.0  1.6 2.5  1.8 1.9  1.4 2.2  1.4 0.07 (0.26 to 0.39)# 0.69
GUG-test (seconds) 10.6  1.8 10.8  2.5 10.2  1.8 10.1  2.7 10.1  1.5 9.7  2.0 10.0  1.6 9.9  2.0 0.26 (0.07 to 0.53) 0.08
PSFL (performance of activities,
0e100)x
53.7  16.4 56.2  17.7 n/a n/a 29.5  18.1 34.4  19.8 31.3  22.1 34.6  20.3 1.01 (6.53 to 4.51) 0.72
WQ35 (walking, 0e100) 23.9  18.1 27.7  22.6 19.8  16.8 24.1  20.6 14.6  15.4 19.4  20.3 17.7  20.4 19.2  20.7 1.15 (5.43 to 3.12)# 0.60
CStQ15 (stair climbing, 0e100) 37.4  20.2 39.4  20.6 32.2  20.4 36.2  21.8 25.3  19.1 27.4  18.8 28.3  22.7 30.8  22.0 0.19 (3.93 to 4.30) 0.93
QR&S39 (rising and sitting
down, 0e100)
35.0  22.3 38.4  25.7 31.4  22.9 32.2  25.5 24.6  20.3 26.6  23.1 29.2  25.3 26.9  24.6 2.07 (2.00 to 6.14)# 0.32
Exp. ¼ experimental group; Con. ¼ control group; CI ¼ conﬁdence interval; ; PSFL ¼ patient speciﬁc functioning list; n/a ¼ not assessed.
* Adjusted for baseline value of outcome variable, presence of self-reported instability affecting daily functioning at baseline, proprioceptive accuracy at baseline and
presence of varus malalignment at baseline.
y Perceived improvement vs no perceived improvement (reference).
z Data from index knee.
x Average score of three activities that were most relevant and problematic for patient.
k Odds ratio (95% CI).
{ Group difference at 12-wk FU.
# Although outcome measure was not optimally distributed, analysis of non-transformed data reported, as this is more easily interpretable and yielded similar results as
analysis with transformed data.
J. Knoop et al. / Osteoarthritis and Cartilage 21 (2013) 1025e1034 1031Major strengths of the present study are a large study population
(n ¼ 159), our selection of patients that were presumed to beneﬁt
from targeted knee joint stabilization training, low drop-out rate
(3%), high patient adherence, consistent study results from multiple
(both global and speciﬁc) outcome measures and the contrast be-
tween treatment arms, which enabled us to determine the isolated
effect of initial knee joint stabilization training. A limitation of the
study might be the non-optimal blinding of the assessor, who
correctly guessed participant’s group allocation in 59%. A second
limitation could be a small but signiﬁcant difference in trainingTable III
Relative change and treatment response by group from baseline to 12-week FU and base
D Baseline-12-week FU
Experimental Control
% D Responders, n (%)* % D Re
Primary outcome
WOMAC (physical function) 31% 52 (66%) 27% 47
Secondary outcomes:
NRS (knee pain severity) 41% 55 (70%) 36% 54
GUG-test 5% 19 (24%) 9% 29
PSFL (performance of daily activities)y 45% 50 (63%) 37% 38
Upper leg muscle strengthz þ18% e þ19% e
Proprioceptive accuracyz 28% e 31% e
WQ35 (walking) 40% e 28% e
CStQ15 (stair climbing) 33% e 29% e
QR&S39 (rising and sitting down) 30% e 29% e
* Based on MCID of 12% for WOMAC35, 15% for NRS pain36, and 20 mm for PSFL27, and
y Average score of three activities that were most relevant and problematic for patien
z Data from index knee.intensity in the last treatment phase in favor of the control treatment,
which could be explained by the instructions to perform exercises in
a controlled manner, only provided in the experimental group,
thereby possibly hindering a larger increase in training intensity.
In conclusion, both exercise programs were highly effective in
reducing activity limitations and pain and restoring knee stability
in knee OA patients with instability of the knee. In knee OA patients
suffering from knee instability, speciﬁc knee joint stabilization
training, in addition to strength training and training of daily ac-
tivities, does not seem to have any additional value.line to 38-week FU (n ¼ 154)
D Baseline-38-week FU
Experimental Control
sponders, n (%)* % D Responders, n (%)* % D Responders, n (%)*
(63%) 25% 49 (62%) 28% 46 (61%)
(72%) 35% 57 (72%) 28% 43 (57%)
(39%) 6% 16 (21%) 8% 25 (34%)
(51%) 42% 43 (56%) 37% 33 (45%)
þ22% e þ23% e
30% e 40% e
27% e 29% e
25% e 20% e
17% e 28% e
minimal detectable change (MDC) of 1.2 s for GUG-test26.
t.
Fig. 5. Outcomes on WOMAC, physical function (a) and NRS, pain severity (b) during study period for control and experimental group separately.
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